Preliminary report of the use on adults of a recombinant yeast-derived hepatitis B vaccine manufactured by Instituto Butantan

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 39, Issue 1, 1997, Pages 39-42

  Costa, Angela Aparecida ^a   Inenami, Marta ^a   Juarez, Edmundo ^a   Llacen, Pedro Dorlhiac ^b   Raw, Isaias ^c  

^a Servico Especial Saude de Araraquara   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

adults; clinical trials; recombinant hepatitis B vaccine

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FATIGUE; HEPATITIS B; HUMAN; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; NAUSEA; SIDE EFFECT; VACCINATION; VERTIGO; VOLUNTEER;

EID: 0030928234     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651997000100008     Document Type: Article

References (14)

1. ANDRÉ, F.E. & SAFARY, A. - Summary of clinical findings on Engerix-B. a genetically engineered yeast-derived hepatitis B vaccine. Postgrad. med. J., 63(suppl. 2):169-178, 1987.
2. BERGAMINI, F. & ZANETTI, A. - Immunogenicity of yeast-derived hepatitis B vaccines in young adults. Postgrad. med., J., 63(suppl. 2):137-138, 1987.
3. DAVIDSON, M. & KRUGMAN, S. - Immunogenicity recombinant yeast hepattis B vaccine. Lancet, 1:108-109, 1985.
4. GONZALEZ, M.L.; USANDIZAGA, M.; ALOMAR, P.; SALVA, F. & MARTIN, F. - Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine, 8:402-405, 1990.
5. GOUDEAU, A.; DENIS, F.; MOUNIER, M. et al. - Comparative multicentre study of the immunogenicity of different hepatitis B vaccines in healthy volunteers. Postgrad. med. J., 63:(suppl. 2):125-128, 1987.
6. HOLLINGER, F.B.; TROISI, C.L. & PEPE, P.E. - Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology in yeast. J. infect. Dis., 153:156-159, 1986.
7. JUST, M.; BERGER, R. & JUST, V. - Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults. Postgrad. med. J., 63(suppl. 2):121-123, 1987.
8. KUBRUSLY, F.S.; IOSHIMOTO, L.M.; MIYAKI, C. et al. - Quality control tests of a recombinant yeast-derived Hepatitis B vaccine (Unpublished data. 1996).
9. KUWERT, E.; SCHEIERMANN, N.; GESEMANN, M. et al. - Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast. Antivir. Res., (suppl 1):281-288, 1985.
10. SEGAL, G.R. - Hepatitis B immunization. Med. J. Aust., 154:70, 1991.
11. WAINWRIGHT, R.B.; McMAHON, B.S.; BULKOW, A.J. et al. - Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. Preliminary results of a 8-year study. In: INTERNATIONAL SYMPOSIUM OF VIRAL HEPATITIS AND LIVER DISEASE. Baltimore, 1990. Proceedings. p. 762-766.
12. WEST, D.J. & CALANDRA, G.B. - Vaccine induced immunologic memory for Hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine, 14:1019-1026, 1996.
13. WHO - Requirements for Hepatitis B vaccines made by recombinant DNA techniques. Wld. Hlth. Org. techn. Rep. Ser., (786), 1989.
14. WIEDERMANN, F.; AMBROSCH, P.; KREMSNER, C. et al. - Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine Postgrad. med. J., 63 (suppl. 2):109-112, 1987.